Abstract
Introduction. Following laboratory studies on new potential chemotherapy for Acanthamoeba keratitis, when chlorhexidine and propamidine provided an additive in vitro effect, a series of 12 patients with culture-proven Acanthamoeba keratitis from three UK centres was monitored during and after therapy.
Methods. In all cases the clinical diagnosis was confirmed by amoebal culture. In some instances identification of the protozoa by direct microscopy of corneal tissue was possible. The medication was provided topically in drop form until the keratitis had resolved. In vitro sensitivity to chlorhexidine and propamidine was performed on all isolates and compared with sensitivity to a range of other drugs used for treatment of the infection.
Results. In vitro drug testing confirmed that trophozoites and cysts of all 12 Acanthamoeba isolates were fully sensitive to chlorhexidine and propamidine. Therapy was satisfactory for controlling and eradicating the acanthamoebal infection in all patients. Three patients developed discrete stromal infiltration at the site of infection that resolved 1 week after commencing therapy, with or without use of steroids. Two patients developed a late inflammatory effect in the stromal scar at 6 months, which resolved with steroids. No clinical evidence of chlorhexidine toxicity was found in any patient.
Conclusions. The combination of topical chlorhexidine and propamidine was very effective for treating Acanthamoeba keratitis provided the drugs were continued for a sufficient period. No drug toxicity or resistance of Acanthamoeba isolates was observed in the 12 treated patients.
Similar content being viewed by others
Article PDF
References
Wright P, Warhurst D, Jones BR . Acanthamoeba keratitis successfully treated medically. Br J Ophthalmol 1985;69:778–82.
Larkin DFP, Kilvington S, Dart JKG . Treatment of Acanthamoeba keratitis with polyhexamethylene biguanide. Ophthalmology 1992;99:185–91.
Varga JH, Wolf TC, Jensen HG, Parmley VC, Rowsey JJ . Combined treatment of Acanthamoeba keratitis with propamidine, neomycin and polyhexamethylene biguanide. Am J Ophthalmol 1993;115:466–70.
Hay J, Kirkness CM, Seal DV, Wright P . Drug resistance and Acanthamoeba keratitis: the quest for alternative antiprotozoal chemotherapy. Eye 1994;8:555–63.
Elder MJ, Kilvington S, Dart JKG . A clinicopathologic study of in vitro sensitivity testing and Acanthamoeba keratitis. Invest Ophthalmol Vis Sci 1994;35:1059–64.
Tirado-Angel J, Gabriel MM, Wilson L, Ahearn R . Effects of polyhexamethylene biguanide and chlorhexidine digluconate on 4 species of free-living Acanthamoeba in vitro. Invest Ophthalmol Vis Sci 1995;36(4, Suppl):S327.
Seal DV, Hay J, Kirkness CM . Chlorhexidine or polyhexamethylene biguanide for Acanthamoeba keratitis. Lancet 1995;345:136.
Booth A, Morrell AJ . Acanthamoeba keratitis. Eye 1994;8:719–20.
Armstrong M . The laboratory investigation of infective keratitis. Br J Biomed Sci 1994;51:65–72.
Hay J, Kinnear F, Kirkness CM, Seal DV . Acanthamoeba keratitis: laboratory diagnosis, characterisation of protozoa and treatment. Scottish Centre Infect Environ Health 1995;29(95/17):90–1.
Seal DV, Hay J, Devonshire P, Kirkness CM . Acanthamoeba and contact lens disinfection: should chlorine be discontinued? Br J Ophthalmol 1993;77:128.
Sarwar N, Griffith GAP, Loudon K, Tullo AB, Efron E . Acanthamoeba keratitis associated with disposable hydrogel contact lenses disinfected daily with chlorine-based care system. J Br Contact Lens Assoc 1993;16:15–8.
Radford CF, Bacon AS, Dart JKG, Minassian DC . Risk factors for Acanthamoeba keratitis in contact lens users: a case-control study. BMJ 1995;310:1567–70.
Seal DV, Hay J . Contact lens disinfection and Acanthamoeba: problems and practicalities. Pharm J 1992;248:717–9.
Hay J, Seal DV, Connor R, Simmons PA, Tomlinson A . Disinfection and sonication: effect on association of Acanthamoeba cysts with an ionic, high water content contact lens. J Br Contact Lens Assoc 1995;18:5–8.
Bacon AS, Dart JKG, Ficker LA, Matheson MM, Wright P . Acanthamoeba keratitis: the value of early diagnosis. Ophthalmology 1993;100:1238–43.
Ficker LA, Kirkness C, Wright P . Prognosis for keratoplasty in Acanthamoeba keratitis. Ophthalmology 1993;100:105–10.
Ficker L, Seal DV, Warhurst D, Wright P . Acanthamoeba keratitis: resistance to medical therapy. Eye 1990;4:835–8.
Gray TB, Gross KA, Cursons RTM, Shewan JF . Acanthamoeba keratitis: a sobering case and a promising new treatment. Aust NZ J Ophthalmol 1994;22:73–6.
Brasseur G, Favennec L, Perrine D, Chenu JP, Brasseur P . Successful treatment of Acanthamoeba keratitis by hexamidine. Cornea 1994;13:456–62.
Perrine D, Chenu JP, Georges P, Lancelot JC, Saturnino C, Robba M . Amoebicidal efficiencies of various diamidines against two strains of Acanthamoeba polyphaga. Antimicrob Ag Chemother 1995;39:339–42.
Pearlman E, Lass JH . Keratitis due to onchocerciasis. Ophthalmol Clin North Am 1994;7:641–8.
Hendricks RL, Tang Q . Cellular immunity and the eye. In: Pepose JS, Holland GN, Wilhelmus KR, editors. Ocular infection and immunity. St Louis: Mosby-Year Book, 1996:71–95.
Dougherty PJ, Binder PS, Mondino BJ, Glasgow BJ . Acanthamoeba sclerokeratitis. Am J Ophthalmol 1994;117:475–9.
Pineda R, Dohlman CH . The role of steroids in the management of Acanthamoeba keratitis, fungal keratitis and epidemic keratoconjunctivitis. Int Ophthalmol Clin 1994;34:19–31.
D'Aversa G, Stern GA, Driebe T . Diagnosis and successful medical treatment of Acanthamoeba keratitis. Arch Ophthalmol 1995;113:1120–3.
Roed A . Effects of chlorhexidine on the isolated rat phrenic nerve-diaphragm preparation. Pharmacol Toxicol 1994;74:10–6.
Zampatti O, Roques Ch, Michel G . An in vitro mouth model to test anti-plaque agents: preliminary studies using a toothpaste containing chlorhexidine. Caries Res 1994:28:35–42.
Pucher JJ, Daniel JC . The effects of chlorhexidine digluconate on human fibroblasts in vitro. J Perio-dontol 1992;63:526–32.
Celdran A, Inarrea P, Fernandez J, Larrocha C, Madero R . Neutrophil dynamics in abdominal cavity of peritonitic rats treated with antiseptics. Int Surg 1993;78:354–6.
Severyns AM, Lejeune A, Rocoux G, Lejeune G . Non-toxic antiseptic irrigation with chlorhexidine in experimental revascularization in the rat. J Hosp Inf 1991;17:197–206.
Archer H, Barnett S, Irving S, Middleton K, Seal DV . A controlled model of moist wound healing: comparison between semi-permeable film, antiseptics and sugar paste. J Exp Pathol 1990;71:155–70.
Niedner R, Schopf E . Inhibition of wound healing by antiseptics. Br J Dermatol 1986;115(Suppl 31):41–4.
Brennan SS, Foster ME, Leaper DJ . Antiseptic toxicity in wounds healing by secondary intention. J Hosp Inf 1986;8:263–7.
Bowes Hamill M, Osato MS, Wilhelmus KR . Experimental evaluation of chlorhexidine gluconate for ocular antiseptics. Antimicrob Ag Chemother 1984;26:793–6.
Platt J, Bucknall RA . An experimental evaluation of antiseptic wound irrigation. J Hosp Inf 1984;5:181–8.
Green K, Livingston V, Bowman K, Hull DS . Chlorhexidine effects on corneal epithelium and endothelium. Arch Ophthalmol 1980;98:1273–8.
Browne RK, Anderson AN, Charvez BW, Azzarello RJ . Ophthalmic response to chlorhexidine digluconate in rabbits. Toxicol Appl Pharmacol 1975;32:621–7.
Hamed LM, Ellis FD, Boudreault G, Wilson FM, Helveston EM . Hibiclens keratitis. Am J Ophthalmol 1987;104:50–6.
Albandar JM, Gjermo P, Preus HR . Chlorhexidine use after two decades of over-the-counter availability. J Periodontol 1994;65:109–12.
Jenkins S, Addy M, Newcombe RG . Dose response of chlorhexidine against plaque and comparison with triclosan. J Clin Periodontol 1994;21:250–5.
Emilson CG . Potential efficacy of chlorhexidine against Mutans streptococci and human dental caries. J Dent Res 1994;73:682–91.
Creel D . Inappropriate use of albino animals as models in research. Pharmacol Biochem Behav 1980;12:969–77.
Bicknell PG . Sensorineural deafness following myringoplasty operations. J Laryngol Otol 1971;85:957–61.
Mills RA, Wilhelmus KR, Osato MS, Pyron M . Polyhexamethylene biguanide in the treatment of Acanthamoeba keratitis. Aust NZ J Ophthalmol 1993;21:277–8.
Mathers WD, Sutphin JE, Folberg R, Meier P, Wenzel RP, Elgin R . Outbreak of keratitis presumed to be caused by Acanthamoeba. Am J Ophthalmol 1996;121:129–42.
Kamel AGM, Norazah A . First case of Acanthamoeba keratitis in Malaysia. Trans R Soc Trop Med Hyg 1995;89:652.
Seal DV, Hay J, Kirkness CM . Acanthamoeba keratitis and contact lens wear: the need for a global strategy for prevention of corneal infection. Community Eye Health 1995;8:4–6.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Seal, D., Hay, J., Kirkness, C. et al. Successful medical therapy of Acanthamoeba keratitis with topical chlorhexidine and propamidine. Eye 10, 413–421 (1996). https://doi.org/10.1038/eye.1996.92
Issue Date:
DOI: https://doi.org/10.1038/eye.1996.92
This article is cited by
-
Cytotoxic effect of organic solvents and surfactant agents on Acanthamoeba castellanii cysts
Parasitology Research (2014)
-
In vitro amoebicidal activities of Satureja cuneifolia and Melissa officinalis on Acanthamoeba castellanii cysts and trophozoites
Parasitology Research (2012)
-
Combined chlorhexidine and PVP-I decontamination of human donor eyes prior to corneal preservation
Cell and Tissue Banking (2012)
-
Acanthamoeba keratitis update—incidence, molecular epidemiology and new drugs for treatment
Eye (2003)
-
Polyhexamethylene biguanide (0.02%) alone is not adequate for treating chronic Acanthameoba keratitis
Eye (2000)